drugset / Trial / NCT03492996
A Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace
NaSingle-groupOpen-labelTreatment
Summary
The primary objectives of the study are: • To assess the absorption, metabolism, excretion of LCB01-0371 after a single oral LCB01-0371 dose with a \[14C\]-LCB01-0371-tracer dose to healthy subjects
Timeline
- Start
- 2020-06-21
- Primary completion
- 2020-08-03
- Completion
- 2020-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Delpazolid | Small molecule | — | Oral |
Indications
No indication recorded.